Bell Investment Advisors, Inc Legend Biotech Corp Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 55 shares of LEGN stock, worth $2,009. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 135
59.26%
Holding current value
$2,009
Previous $6,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$274 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$249 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$219 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$209 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$209 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.12B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...